Skip to main content
Contact Us
Subscribe
E-Edition
60°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Prime Medicine Inc
(NQ:
PRME
)
4.920
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
10
Open
4.920
Bid (Size)
4.700 (1)
Ask (Size)
5.210 (1)
Prev. Close
4.920
Today's Range
4.920 - 4.920
52wk Range
4.110 - 15.75
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
April 29, 2024
Via
Benzinga
Tesla, Deciphera Pharmaceuticals, Heartland Financial And Other Big Stocks Moving Higher On Monday
April 29, 2024
Via
Benzinga
Performance
YTD
-43.84%
-43.84%
1 Month
-27.22%
-27.22%
3 Month
-27.54%
-27.54%
6 Month
-24.19%
-24.19%
1 Year
-64.88%
-64.88%
More News
Read More
Recap: Prime Medicine Q4 Earnings
March 01, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
April 29, 2024
Via
InvestorPlace
Prime Medicine Announces FDA Clearance of Investigational New Drug (IND) Application for PM359 for the Treatment of Chronic Granulomatous Disease (CGD)
April 29, 2024
From
Prime Medicine, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
April 26, 2024
Via
Benzinga
Prime Medicine to Present Preclinical Data Demonstrating Broad Potential of Prime Editing Technology at Upcoming Scientific Meetings
April 23, 2024
From
Prime Medicine, Inc.
Via
GlobeNewswire
2 Magnificent Growth Stocks With Room to Run
March 27, 2024
Via
The Motley Fool
Short-Squeeze Roulette: 3 Stocks That Could Leave Bears Begging
March 14, 2024
Via
InvestorPlace
Cathie Wood Just Bought These 3 Biotech Stocks. Should You Buy, Too?
March 01, 2024
Via
InvestorPlace
Prime Medicine Reports Full Year 2023 Financial Results and Provides Business Updates
March 01, 2024
From
Prime Medicine, Inc.
Via
GlobeNewswire
Prime Medicine to Participate in Upcoming Investor Conferences
February 28, 2024
From
Prime Medicine, Inc.
Via
GlobeNewswire
Prime Medicine Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
February 20, 2024
From
Prime Medicine, Inc.
Via
GlobeNewswire
Prime Medicine Announces Pricing of Upsized Public Offering
February 14, 2024
From
Prime Medicine, Inc.
Via
GlobeNewswire
Prime Medicine Announces Proposed Public Offering of Common Stock
February 14, 2024
From
Prime Medicine, Inc.
Via
GlobeNewswire
Prime Medicine to Present at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
February 01, 2024
From
Prime Medicine, Inc.
Via
GlobeNewswire
Prime Medicine Receives Up to $15 Million from Cystic Fibrosis Foundation to Advance Hotspot and PASSIGE™ Prime Editors for Cystic Fibrosis
January 25, 2024
From
Prime Medicine, Inc.
Via
GlobeNewswire
2 gene editing stocks to keep on your 2024 watchlist
January 23, 2024
Via
MarketBeat
Exposures
Product Safety
Morgan Stanley Reports Q4 Results, Joins Boeing, Alcoa And Other Big Stocks Moving Lower On Tuesday
January 16, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Prime Medicine Appoints Allan Reine, M.D., as Chief Financial Officer
January 05, 2024
From
Prime Medicine, Inc.
Via
GlobeNewswire
Prime Medicine to Present at 42nd Annual J.P. Morgan Healthcare Conference
January 02, 2024
From
Prime Medicine, Inc.
Via
GlobeNewswire
Why AAR Shares Are Trading Lower By 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
December 22, 2023
Via
Benzinga
Better Growth Stock: Archer Aviation or Prime Medicine?
December 19, 2023
Via
The Motley Fool
You Don't Have to Pick a Winner in Gene-Editing. Do This Instead.
December 04, 2023
Via
The Motley Fool
1 Cathie Wood Stock That Could Deliver Life-Changing Returns in 10 Years
November 30, 2023
Via
The Motley Fool
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.